Form 4: Kathy Ordonez Executes Stock Options in Pacific Biosciences
SEC Form 4 Filing
Director Kathy Ordonez exercised stock options in Pacific Biosciences, acquiring and disposing of shares on March 15, 2024.
Summary
- On March 15, 2024, Kathy Ordonez, a director of Pacific Biosciences of California, Inc., executed stock options.
- She acquired 324,515 shares of common stock at a price of $2.90 and disposed of 343,110 shares.
- Additionally, she acquired 37,106 shares at $2.63 and now beneficially owns 380,216 shares.
- The transactions involved the exercise of stock options that were fully vested and exercisable.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock option exercises. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of earliest transaction: Stock options exercised, shares acquired and disposed of. |
| 03/19/2024 | Date of signature on the Form 4 filing. |
| 11/15/2027 | Expiration date of one of the stock option grants. |
| 03/15/2028 | Expiration date of one of the stock option grants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.